How effective is Depakote for Schizoaffective Disorder ?


Summary

6 Depakote users have rated its effectiveness for Schizoaffective disorder.

Overall ratings: 3/5
Long term ratings: 3/5

This is a reivew of how effective Depakote (divalproex sodium) is for Schizoaffective disorder and for what kind of people. The study is created by eHealthMe and is updated continuously.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Jul, 01, 2017

6 people are studied for taking Depakote in Schizoaffective disorder


Overall effectiveness (number of people)

Does Depakote work for your Schizoaffective disorder (overall)?

Long term effectiveness (number of people)

Does Depakote work for your Schizoaffective disorder (long term)?

Depakote effectiveness for Schizoaffective disorder (number of people)

Overall:
  • not at all: 0
  • somewhat: 0
  • moderate: 6
  • high: 0
  • very high: 0
Long Term:
  • not at all: 0
  • somewhat: 0
  • moderate: 5
  • high: 0
  • very high: 0

Gender of people who take Depakote for Schizoaffective disorder *

  • female: 33.33 %
  • male: 66.67 %

Age of people who take Depakote for Schizoaffective disorder *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 33.33 %
  • 30-39: 0.0 %
  • 40-49: 66.67 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Who finds Depakote more effective for Schizoaffective Disorder?


* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

You can also:

Depakote

Depakote has active ingredients of divalproex sodium. It is often used in bipolar disorder. (latest outcomes from Depakote 40,622 users)

Schizoaffective Disorder

Schizoaffective disorder (a mental disorder characterized by disordered thought) has been reported by people with schizoaffective disorder, depression, schizophrenia, bipolar disorder, insomnia (latest reports from 10,471 Schizoaffective disorder patients).

Related studies: